Capricor Therapeutics Inc (CAPR)
6.20
+0.56
(+9.93%)
USD |
NASDAQ |
May 17, 16:00
6.22
+0.02
(+0.32%)
After-Hours: 20:00
Capricor Therapeutics Max Drawdown (5Y): 98.99% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 98.99% |
March 31, 2024 | 98.99% |
February 29, 2024 | 98.99% |
January 31, 2024 | 98.99% |
December 31, 2023 | 98.99% |
November 30, 2023 | 98.99% |
October 31, 2023 | 98.99% |
September 30, 2023 | 98.99% |
August 31, 2023 | 98.99% |
July 31, 2023 | 98.99% |
June 30, 2023 | 98.99% |
May 31, 2023 | 98.99% |
April 30, 2023 | 98.99% |
March 31, 2023 | 98.99% |
February 28, 2023 | 98.99% |
January 31, 2023 | 98.99% |
December 31, 2022 | 98.99% |
November 30, 2022 | 98.99% |
October 31, 2022 | 98.99% |
September 30, 2022 | 98.99% |
August 31, 2022 | 98.99% |
July 31, 2022 | 98.99% |
June 30, 2022 | 98.99% |
May 31, 2022 | 98.99% |
April 30, 2022 | 98.99% |
Date | Value |
---|---|
March 31, 2022 | 98.99% |
February 28, 2022 | 98.99% |
January 31, 2022 | 98.99% |
December 31, 2021 | 98.99% |
November 30, 2021 | 98.99% |
October 31, 2021 | 98.99% |
September 30, 2021 | 98.99% |
August 31, 2021 | 98.99% |
July 31, 2021 | 98.99% |
June 30, 2021 | 98.99% |
May 31, 2021 | 98.99% |
April 30, 2021 | 98.99% |
March 31, 2021 | 98.99% |
February 28, 2021 | 98.99% |
January 31, 2021 | 98.99% |
December 31, 2020 | 98.99% |
November 30, 2020 | 98.99% |
October 31, 2020 | 98.99% |
September 30, 2020 | 98.99% |
August 31, 2020 | 98.99% |
July 31, 2020 | 98.99% |
June 30, 2020 | 98.99% |
May 31, 2020 | 98.99% |
April 30, 2020 | 98.99% |
March 31, 2020 | 98.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.33%
Minimum
May 2019
98.99%
Maximum
Dec 2019
98.83%
Average
98.99%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
Sarepta Therapeutics Inc | 64.93% |
PTC Therapeutics Inc | 73.78% |
Solid Biosciences Inc | 99.61% |
Inovio Pharmaceuticals Inc | 98.90% |
Stereotaxis Inc | 86.04% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -45.40 |
Beta (5Y) | 4.057 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 195.3% |
Historical Sharpe Ratio (5Y) | -0.001 |
Historical Sortino (5Y) | -0.0043 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.34% |